| 2024-10-04 | +0.65 % |
|
| 2024-10-03 | -1.33 % |
|
| 2024-09-05 | -9.9 % |
|
| 2024-08-08 | -11.34 % |
|
| 2024-08-06 | +0.22 % |
|
| 2024-08-02 | +0.21 % |
|
| 2024-07-09 | -0.46 % |
|
| 2024-06-25 | -0.56 % |
|
| 2024-06-11 | |
|
| 2024-06-05 | +1.02 % |
|
| 2024-06-03 | +0.63 % |
|
| 2024-05-31 | +1.54 % |
|
| 2024-05-28 | -2.05 % |
|
| 2024-05-14 | -0.55 % |
|
| 2024-05-09 | +2.12 % |
|
| 2024-05-08 | -0.39 % |
|
| 2024-05-07 | +2.31 % |
|
| 2024-04-29 | -1.33 % |
|
| 2024-04-26 | +0.62 % |
|
| 2024-04-24 | +0.64 % |
- The article discusses McKesson Corporation (MCK) stock, which was up by 0.64% last night, and attributes the increase to the declaration by the Board of Directors of a regular dividend of 62 cents per share of common stock, payable on July 1, 2024.
- The article discusses how McKesson Corporation's (MCK) stock rose by 0.64% after Leerink Partners analysts increased their Q3 2025 earnings per share estimates for McKesson, with a new forecast of $8.23 per share, attributing the rise to positive analyst reports, including an "Outperform" rating by Leerink Partners, citing strong earnings and growth prospects.
- The article discusses the increase in McKesson Corporation(MCK) stock by 0.64% following raised EPS estimates by investment analysts at Leerink Partnrs, with the company expected to earn $7.45 per share for Q2 2025 and $27.59 per share for the full year, attributing the rise in stock to positive analyst forecasts and overall favorable financial performance in recent quarters.
|
| 2024-04-23 | +0.89 % |
|
| 2024-04-22 | +0.47 % |
|
| 2024-04-11 | -1.25 % |
- The article discusses Prime Capital Investment Advisors LLC increasing its holdings in McKesson Corporation (MCK) stock by 30.4% in the fourth quarter, highlighting various institutional investors adding shares recently. The stock price was down by -1.25% as of the last night's trading. The stock price might have gone down due to the announcement of quarterly earnings results, recent insider selling by the CEO and EVP, as well as market factors impacting the healthcare industry.
- The article discusses Mirae Asset Global Investments Co. Ltd. reducing its position in shares of McKesson Corporation (MCK) by 16.4%, leading to a -1.25% decline in the stock. The decrease in the stock price could be attributed to institutional investors selling off shares and some executives, like EVP Leann B. Smith and CEO Brian S. Tyler, also selling significant amounts of stock.
- The article discusses McKesson Corporation's (MCK) stock, which was down by -1.25% as of the previous night, despite shares rising 1.7% during mid-day trading after Argus raised their price target to $570.00; the stock decline is attributed to a decrease in trading volume, with analysts offering varying ratings on the stock such as "outperform" and "neutral," as well as institutional investors buying and selling shares while CEOs and executives have recently sold shares.
|
| 2024-04-10 | +0.51 % |
|
